The IFT80 antibody is a polyclonal antibody designed to detect the intraflagellar transport protein 80 (IFT80), a critical component of IFT complex B. IFT80 is essential for ciliogenesis and regulates signaling pathways such as Hedgehog (Hh) and Wnt, which are pivotal for bone development, chondrocyte differentiation, and intervertebral disc formation . This antibody is widely used in research to study cilia dynamics, osteogenesis, and developmental disorders linked to IFT80 dysfunction, such as Jeune asphyxiating thoracic dystrophy (JATD) and short rib polydactyly type III (SRPIII) .
Used to visualize cilia and IFT80 localization in cells. Protocols involve:
Fixation: Methanol (100%, 10 min) or paraformaldehyde (4%, 15–30 min) .
Primary antibody incubation: 1:500 dilution (e.g., Abnova anti-IFT80) for 1–2 hours .
Secondary antibodies: Alexa Fluor-conjugated (488/568/647) for cilia markers like acetylated tubulin or γ-tubulin .
IFT80 colocalizes with cilia markers (acetylated tubulin, γ-tubulin) in wild-type cells but is absent in IFT80-silenced cells .
Cilia loss in IFT80-deficient cells correlates with reduced Arl13b expression .
Detects IFT80 protein in lysates. Protocols include:
IFT80 knockdown reduces protein levels by >80% in mouse BMSCs .
IFT80 depletion disrupts Hh-Gli signaling (e.g., reduced Gli2 expression) .
Analyzes tissue-specific IFT80 expression. Protocols involve:
IFT80 is essential for cilia assembly:
Silencing IFT80: Reduces cilia length (>80% loss) and disrupts acetylated tubulin localization .
Cilia-dependent signaling: IFT80 regulates Hh-Gli activation by controlling Smoothened (Smo) ciliary trafficking .
Canonical pathway: IFT80 promotes Hh-Gli signaling by stabilizing Gli2 and enhancing luciferase activity in response to Sonic Hedgehog (Shh) .
Non-canonical pathway: IFT80 inhibits Hh-Gαi-RhoA-ROCK signaling, preventing stress fiber formation .
IFT80 indirectly modulates Wnt/β-catenin pathways through cilia-dependent mechanisms .
Bone Disorders: IFT80 mutations cause JATD/SRPIII, characterized by skeletal dysplasia .
Intervertebral Disc Degeneration: IFT80 deletion in type II collagen-positive cells disrupts nucleus pulposus (NP) structure and reduces chondrogenic markers (e.g., collagen II, aggrecan) .
IFT80 is a critical component of the intraflagellar transport (IFT) complex B, which plays an essential role in the development and maintenance of both motile and sensory cilia. It contributes to the assembly and proper positioning of ciliary components through the intraflagellar transport system . IFT80 is also known as WDR56 (WD repeat-containing protein 56) and encoded by the gene IFT80 (intraflagellar transport 80 homolog). The protein has a calculated molecular weight of approximately 88 kDa . At the cellular level, IFT80 functions to transport cargo proteins along the ciliary axoneme, which is crucial for ciliogenesis and ciliary signaling pathways. This transport mechanism is essential for numerous developmental processes and cellular functions that rely on proper cilia formation.
IFT80 antibodies support multiple experimental applications with varying degrees of optimization:
When selecting an antibody, researchers should verify specific reactivity with their target species. For example, Proteintech's antibody (25230-1-AP) has confirmed reactivity with human and mouse samples, while Abnova's antibody (PAB15842) is specifically validated for mouse samples .
For Western blot applications, optimal sample preparation depends on the cellular localization of IFT80. Since IFT80 is predominantly associated with cilia and intracellular transport structures, a lysis buffer containing both detergent and mechanical disruption is recommended. Based on published protocols, cells should be lysed in a buffer containing protease inhibitors to prevent degradation, as IFT80 can be susceptible to proteolytic cleavage.
For tissue samples:
Homogenize fresh or flash-frozen tissue in RIPA buffer supplemented with protease inhibitors
Incubate on ice for 30 minutes with occasional vortexing
Centrifuge at 12,000 g for 20 minutes at 4°C
Collect supernatant and determine protein concentration
For adherent cell cultures like NIH/3T3 (where IFT80 antibodies show positive results), scrape cells in PBS followed by centrifugation and resuspension in lysis buffer . When processing intervertebral disc tissues, special considerations are needed due to the high proteoglycan content which can interfere with protein extraction .
When optimizing Western blots for IFT80 detection, consider these methodological approaches:
Sample loading: Load 30-50 μg of total protein per lane as indicated in validated protocols
Gel percentage: Use 5% SDS-PAGE gels for optimal separation of the 88-90 kDa IFT80 protein
Transfer conditions: Wet transfer at lower voltage (30V) overnight at 4°C improves transfer efficiency of larger proteins
Blocking conditions: 5% non-fat milk in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature
Antibody dilution: Start with manufacturer's recommended dilution (e.g., 1:500 for ab154933 or 1:500-1:2000 for 25230-1-AP)
Incubation time: Primary antibody incubation overnight at 4°C improves signal quality
Detection method: Enhanced chemiluminescence (ECL) with extended exposure times may be necessary
If non-specific bands appear, additional blocking with 2% BSA or increasing wash stringency can improve specificity. The predicted molecular weight of IFT80 is 88 kDa, with observed bands typically between 88-90 kDa .
IFT80 plays a critical role in bone development and healing, requiring specialized experimental approaches to investigate its functions. Research has shown that IFT80 is essential for fracture healing through its regulation of TGF-β signaling in chondrocytes . When designing experiments to study IFT80 in bone contexts, consider:
Model selection: Conditional knockout models using bone/cartilage-specific Cre drivers (Col2a1-Cre for growth plate and Col1a1-Cre for mature bone cells) have been successfully used to study IFT80 function in vivo
Timepoint selection: For fracture healing studies, early timepoints (days 7-14) are critical as IFT80 expression is most pronounced during the initial healing phases
Protein extraction: Bone tissues require specialized extraction protocols due to their mineralized nature; demineralization steps may be necessary
Complementary techniques: Combine IHC/IF with μCT imaging and biomechanical testing for comprehensive analysis
Recent published research demonstrates that deletion of IFT80 in type II collagen-positive cells disrupts growth plate organization, while deletion in type I collagen-positive cells affects outer annulus fibrosus alignment . This suggests cell type-specific functions of IFT80 that should be considered when designing targeted experiments.
IFT80 negatively regulates osteoclast differentiation through a TRAF6-dependent mechanism . To investigate this relationship:
In vitro osteoclastogenesis assays: Culture bone marrow-derived macrophages (BMMs) with RANKL and M-CSF, with and without IFT80 manipulation
TRAP staining: Quantify osteoclast formation by TRAP-positive multinucleated cell counting
Actin ring formation assays: Assess osteoclast function through visualization of actin rings
Acridine orange assays: Measure acid production capacity of mature osteoclasts
Gene expression analysis: Monitor osteoclast markers including TRAP, Ctsk, Dc-stamp, and Atp6v0d2
Research has demonstrated that IFT80 deletion using LysM-Cre (for osteoclast precursors) or Ctsk-Cre (for mature osteoclasts) results in:
Increased osteoclast numbers (4-fold increase in TRAP+ cells)
Enhanced actin ring formation (3-fold increase)
Higher acid content production (1.8-fold increase)
Elevated expression of osteoclast-specific genes
Significant bone loss (7-fold decrease in bone volume/total volume)
When investigating the mechanism, focus on TRAF6 protein levels and stability, as IFT80 appears to regulate TRAF6 through modulation of Cbl-mediated proteasomal degradation pathways .
Given IFT80's critical role in ciliogenesis and ciliary function, specific experimental approaches can elucidate its relationship to ciliopathies and hedgehog signaling:
Ciliary visualization techniques:
Immunofluorescence using antibodies against ciliary markers (acetylated α-tubulin, Arl13b) alongside IFT80
Super-resolution microscopy for detailed ciliary substructure examination
Live-cell imaging using fluorescently tagged IFT80 to track dynamics
Hedgehog pathway assessment:
Gli1 and Patched1 expression analysis as direct readouts of pathway activity
Gli reporter assays (e.g., 8xGliBS-luciferase) for quantitative measurements
SHH stimulation experiments with or without IFT80 manipulation
Disease modeling approaches:
CRISPR/Cas9-mediated introduction of patient-specific IFT80 mutations
Patient-derived iPSCs differentiated into relevant cell types
Conditionally inducible systems to study temporal requirements
Research has shown that loss of IFT80 causes marked decrease in hedgehog signaling components, including Gli1 and Patched1, in intervertebral disc tissues . This indicates that experiments should focus on tissue-specific effects of IFT80 disruption on hedgehog pathway function.
Intervertebral disc (IVD) development studies require specialized approaches when investigating IFT80 function:
Tissue-specific considerations:
The IVD comprises three distinct regions: nucleus pulposus (NP), annulus fibrosus (inner and outer), and endplates
Each region requires different extraction and preparation protocols
IFT80 functions differ between regions, necessitating region-specific analysis
Ex vivo organ culture system:
Phenotypic analysis:
Histological assessment of disc architecture using H&E, Safranin O, and Alcian blue stains
Immunohistochemical detection of type I and type II collagen distribution
Gene expression analysis of chondrogenic markers (Col2a1, Sox9, Aggrecan)
Deletion of IFT80 in type II collagen-expressing cells disrupts IVD structure with disorganized and decreased growth plate, endplate, and inner annulus fibrosus, while deletion in type I collagen-expressing cells affects the outer annulus fibrosus organization . These differential effects emphasize the importance of cell type-specific approaches when studying IFT80 in the IVD.
Proper experimental controls are essential for reliable IFT80 antibody-based studies:
Positive controls:
Negative controls:
Primary antibody omission controls
IFT80 knockout or knockdown samples (when available)
Non-ciliated cell lines as functional negative controls
Loading controls:
β-actin or GAPDH for Western blot normalization
For ciliary studies, acetylated α-tubulin or other ciliary markers for co-localization
Specificity controls:
Pre-absorption with immunizing peptide
Secondary antibody-only controls
Isotype-matched irrelevant antibody controls
When validating a new lot of antibody, comparison with previously validated lots using consistent positive control samples is recommended for ensuring consistency across experiments.
Quantitative assessment of IFT80 expression requires rigorous methodological approaches:
Western blot densitometry:
Normalize IFT80 signal to loading controls
Use calibration curves with recombinant standards for absolute quantification
Employ technical replicates and biological replicates (minimum n=3)
qRT-PCR for transcript levels:
Design primers spanning exon-exon junctions
Validate primer efficiency using standard curves
Normalize to multiple reference genes for accuracy
Consider using digital PCR for absolute quantification
Image analysis for immunofluorescence/IHC:
Apply consistent threshold settings across experimental groups
Measure staining intensity, area, and co-localization parameters
Use automated analysis algorithms to reduce bias
Report both signal intensity and percentage of positive cells
Flow cytometry:
Quantify IFT80 expression at the single-cell level
Assess population heterogeneity in expression levels
Gate on appropriate cell populations
For IFT80 knockdown validation, a combination of mRNA and protein quantification is recommended, as post-transcriptional regulatory mechanisms may affect protein levels independently of transcript changes.
Recent research is expanding our understanding of IFT80 beyond its classic role in ciliogenesis:
Signaling pathway integration:
IFT80 negatively regulates osteoclast differentiation through TRAF6-dependent mechanisms
Potential involvement in non-canonical Wnt signaling pathways
Cross-talk with TGF-β signaling during bone healing
Cell type-specific functions:
Differential roles in type I versus type II collagen-expressing cells
Cell-autonomous versus non-cell-autonomous effects on tissue development
Lineage-specific requirements during differentiation processes
Therapeutic targeting potential:
IFT80 manipulation as a strategy to enhance bone healing
Ciliary-targeted approaches for treating ciliopathies caused by IFT80 mutations
Small molecule modulators of IFT80 function or stability
Experimental approaches to explore these emerging areas should combine traditional biochemical methods with advanced imaging techniques, single-cell analysis, and in vivo functional studies with tissue-specific genetic manipulations.
To identify and characterize IFT80 protein-protein interactions:
Co-immunoprecipitation approaches:
Use IFT80 antibodies to pull down protein complexes
Validate interactions with reciprocal IP experiments
Consider crosslinking to stabilize transient interactions
Proximity labeling methods:
BioID or TurboID fusion proteins to identify proximal proteins
APEX2-based approaches for temporal control
Consider ciliary-targeted constructs for organelle-specific interactome mapping
Mass spectrometry-based approaches:
Quantitative proteomics comparing wild-type versus IFT80-deficient samples
SILAC or TMT labeling for more precise quantification
Focused analysis of ciliary fractions to enrich for relevant interactors
Yeast two-hybrid screening:
Use domain-specific baits to identify direct binding partners
Validate hits with biochemical approaches
Consider membrane yeast two-hybrid for transmembrane interactors
Fluorescence-based interaction detection:
FRET/FLIM to detect protein-protein interactions in live cells
BiFC to visualize interaction events in specific subcellular compartments
FCCS to measure interaction kinetics in living cells
Current research suggests potential interactions with both IFT complex components and signaling molecules like TRAF6 and Cbl proteins, which could be promising starting points for interaction studies .